Document is current
Any future updates will be listed below
-
Authors
Benevent, Justine https://orcid.org/0000-0001-9048-5336
Araujo, Mélanie https://orcid.org/0000-0003-3057-9554
Beau, Anna-Belle https://orcid.org/0000-0003-4631-100X
Sicard, Diane
Sommet, Agnès https://orcid.org/0000-0001-7980-5650
Hurault-Delarue, Caroline https://orcid.org/0000-0001-7651-9130
Lacroix, Isabelle https://orcid.org/0000-0001-7344-7282
Damase-Michel, Christine https://orcid.org/0000-0001-5018-0108
-
Funding
Funding for this research was provided by:
Agence Nationale de Sécurité du Médicament et des Produits de Santé (AAP-2018-REGARDS)
- License Information
-
More Information
Article History
Received: 26 October 2021
Accepted: 21 May 2022
First Online: 11 June 2022
Declarations
:
: Justine Benevent, Mélanie Araujo, Anna-Belle Beau, Diane Sicard, Agnès Sommet, Caroline Hurault-Delarue, Isabelle Lacroix, and Christine Damase-Michel declare that they have no competing interests to declare that are relevant to the content of this article.
: The EFEMERIS cohort was approved by the French Data protection Agency on 7 April 2005 (authorization number 05–1140). This study was performed on anonymized patient data.
: The women included in EFEMERIS were informed of their inclusion and of the potential use of their anonymized data for research purposes. They can oppose the use of their data at any time.
: The women included in EFEMERIS know that their gathered and anonymized data can be used for medical research purposes and can thus be published.All authors agreed with the content and that all gave explicit consent to submit.
